Skip to content
Wenlo
Sign in
← Markets

Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. (ACRS) — Form 8-K: Current report

8-KACRSFiled Oct 27, 2026, 1:25 PM ET· Period Oct 27, 2026

About this filing

Aclaris Therapeutics, Inc. (ACRS) filed an 8-K on Oct 27, 2026 reporting entry into a material agreement (Item 1.01), with exhibits (Item 9.01).

Key facts

  • Item 1.01 · Entry into a material agreement
  • Item 9.01 · Financial statements and exhibits

More ACRS filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.